DKNG vs GYRE · rev $6.05B vs rev $53.5M
DraftKings Inc (DKNG) versus Gyre Therapeutics Inc. (GYRE) — a side-by-side from cached financials, not a winner call.
DraftKings Inc (DKNG) is a gambling company listed on US.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Latest reported DKNG revenue for 2025-12-31 was $6.05B. Net income was $3.7M. Revenue was up 27.0% from 2024-12-31 to 2025-12-31. DKNG currently screens at market cap $20.96B.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
DKNG currently screens at market cap $20.96B. GYRE currently screens at market cap $589.9M.
Not investment advice. Open the DKNG and GYRE stock pages for the full models.
Not investment advice.